Aurion Biotech, Inc. (AURN)

Aurion Biotech was planning to go public, but the IPO was withdrawn on May 23, 2025.

Stock Price: Pending

IPO price not available yet

Aurion Biotech Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Income	-60.37	-47.35	-34.57
Net Income	-59.92	-45.55	-35.69

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	52.07	41.35	18.87
Total Debt	62.55	6.69	7.71
Net Cash (Debt)	-10.49	34.66	11.16
Net Cash Growth	-	210.65%	-

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-51.88	-41.37	-32.35
Capital Expenditures	-0.79	-1.24	-1.51
Free Cash Flow	-52.67	-42.61	-33.86
Free Cash Flow Growth	-	-	-